These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4258880)

  • 1. [Ultra-micro-determination of plasmin using a fibrin plate. 3. Relationship to antiplasmin agents].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Dec; 19(12):859-62. PubMed ID: 4258880
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ultramicro determination of plasmin using fibrin plate. 2. Determination of antiplasmin activity].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Oct; 19(10):701-3. PubMed ID: 4259643
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ultramicro determination of plasmin using fibrin plate. 1. Determination of plasmin activity].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Sep; 19(9):641-4. PubMed ID: 4258462
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative studies of fibrinolytic inhibitors in vitro.
    Maki M; Beller FK
    Thromb Diath Haemorrh; 1966 Dec; 16(3):668-86. PubMed ID: 4231539
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha-2 plasmin inhibitor-plasmin complex and postoperative blood loss: double-blind study with aprotinin in reoperation for myocardial revascularization.
    Minami K; Notohamiprodjo G; Buschler H; Prohaska W; Reichelt W; Körfer R
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):934-6. PubMed ID: 7694000
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrin deposition in the ribbit kidney produced by protease inhibitors.
    Beller FK; Mitchell PS; Gorstein F
    Thromb Diath Haemorrh; 1967 May; 17(3-4):427-39. PubMed ID: 5301528
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Mar; 19(3):223-6. PubMed ID: 4252723
    [No Abstract]   [Full Text] [Related]  

  • 10. On the heterogeneity of activity by various types of plasmins and the spectra of inhibition of some plasmin inhibitors.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):67-85. PubMed ID: 4257701
    [No Abstract]   [Full Text] [Related]  

  • 11. [FIBRINOLYSIS AND ANTIFIBRINOLYTIC THERAPY IN UROLOGIC OPERATIONS. EXAMINATIONS USING A NEW METHOD FOR MEASURING FIBRINOLYSIS].
    PIPER W; BUCHBERGER HG; SIMON S; KRUEGER J
    Med Welt; 1965 Feb; 8():385-96. PubMed ID: 14262868
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrin powder turbidity measurement for rapid assessment of antiplasmins.
    Exner T; Rickard KA; Kronenberg H
    Am J Clin Pathol; 1975 Nov; 64(5):597-601. PubMed ID: 127526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on antiphlogistic effects of fibrinolysin inhibitors].
    Feyen H; Nissen H; Rasche H; Hiemeyer V
    Z Rheumaforsch; 1970; 29(9):276-86. PubMed ID: 4394179
    [No Abstract]   [Full Text] [Related]  

  • 14. [The inhibitors of fibrinolysis: new information on antifibrinolytic agents].
    Giacomazzi G
    Haematologica; 1968; 53(7):489-533. PubMed ID: 4976851
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trypsin inhibition by new antifibrinolytics].
    Gülzow M; Mix H; Trettin HJ
    Hoppe Seylers Z Physiol Chem; 1967 Mar; 348(3):285-8. PubMed ID: 5589206
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin.
    Abiko Y; Iwamoto M
    Biochim Biophys Acta; 1970 Sep; 214(3):411-8. PubMed ID: 4251764
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of gastric plasmin activity by epsilon-aminocaproic acid.
    Thomson JM; Turner L; Poller L
    Ann R Coll Surg Engl; 1973 Dec; 53(6):340-7. PubMed ID: 4271260
    [No Abstract]   [Full Text] [Related]  

  • 19. On the action mechanism of some fibrinolysis inhibitors.
    Donner L; Housková J
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):439-46. PubMed ID: 4952977
    [No Abstract]   [Full Text] [Related]  

  • 20. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.